Sorafenib versus transarterial chemoembolization plus external beam radiotherapy in patients with hepatocellular carcinoma with major vascular invasion (START): a randomized phase 2 trial

被引：0
|
作者：
Yoon, Sang Min [1 ]
Lee, So Jung [2 ]
Kim, Jong Hoon [1 ]
Shin, Ji Hoon [2 ]
An, Jihyun [3 ]
Lee, Danbi [3 ]
Shim, Ju Hyun [3 ]
Lee, Han Chu [3 ]
Ryoo, Baek-Yeol [4 ]
Lim, Young-Suk [3 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Radiat Oncol, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Radiol, Seoul, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Gastroenterol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Med Oncol, Seoul, South Korea
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1360
引用
收藏
页码：729A / 729A
页数：1
相关论文
共 50 条
  • [31] Transarterial chemoembolization combined with apatinib versus transarterial chemoembolization alone for hepatocellular carcinoma with macroscopic vascular invasion: A propensity score matching analysis
    Shen, Lujun
    Chen, Shuanggang
    Qiu, Zhiyu
    Qi, Han
    Yuan, Hui
    Cao, Fei
    Xie, Lin
    Chen, Qifeng
    Li, Wang
    Fan, Weijun
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (05) : 1063 - 1068
  • [32] Combined transarterial chemoembolization and external beam radiotherapy for identifying surgical candidates for hepatocellular carcinoma with macroscopic vascular invasion: A propensity score-weighted analysis.
    Yoon, Sang Min
    Lee, Sumin
    Jung, Jinhong
    Choi, Jonggi
    Shim, Ju Hyun
    Song, Gi-Won
    Park, Jin-hong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 562 - 562
  • [33] Sorafenib plus hepatic arterial infusion of oxaliplatin and fluorouracil vs sorafenib plus transarterial chemoembolization for advanced hepatocellular carcinoma: A biomolecular exploratory, randomized, phase III trial (SHATA-001).
    Lai, Zhicheng
    Kan, Anna
    He, Minke
    Du, Zefeng
    Shi, Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [34] Safety and Efficacy of Transcatheter Arterial Chemoembolization Plus Radiotherapy Combined with Sorafenib in Hepatocellular Carcinoma with Macrovascular Invasion
    Zhu, X. G.
    Zhao, Y.
    Chen, B.
    Wang, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E230 - E231
  • [35] Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study
    Zhang, Lei
    Sun, Jun-Hui
    Hou, Zhong-Heng
    Zhong, Bin-Yan
    Yang, Min-Jie
    Zhou, Guan-Hui
    Wang, Wan-Sheng
    Huang, Peng
    Zhang, Shen
    Li, Zhi
    Zhu, Xiao-Li
    Yan, Zhi-Ping
    Ni, Cai-Fang
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2021, 44 (01) : 63 - 72
  • [36] A prognostic score model for predicting the survival benefits of patients undergoing sorafenib plus transarterial chemoembolization for hepatocellular carcinoma with portal vein invasion
    Li, Ji-Rong
    Wu, Min-Jiang
    Wang, Tan
    Tian, Min
    Zhou, Guang
    Liu, Qing-Xiong
    Xiang, Xian-Hong
    Zhang, Ying-Qiang
    ABDOMINAL RADIOLOGY, 2021, 46 (05) : 1967 - 1976
  • [37] Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study
    Lei Zhang
    Jun-Hui Sun
    Zhong-Heng Hou
    Bin-Yan Zhong
    Min-Jie Yang
    Guan-Hui Zhou
    Wan-Sheng Wang
    Peng Huang
    Shen Zhang
    Zhi Li
    Xiao-Li Zhu
    Zhi-Ping Yan
    Cai-Fang Ni
    CardioVascular and Interventional Radiology, 2021, 44 : 63 - 72
  • [38] A prognostic score model for predicting the survival benefits of patients undergoing sorafenib plus transarterial chemoembolization for hepatocellular carcinoma with portal vein invasion
    Ji-Rong Li
    Min-Jiang Wu
    Tan Wang
    Min Tian
    Guang Zhou
    Qing-Xiong Liu
    Xian-Hong Xiang
    Ying-Qiang Zhang
    Abdominal Radiology, 2021, 46 : 1967 - 1976
  • [39] Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation
    Zhang, Xia
    Cai, Lirong
    Fang, Jian
    Chen, Fengsui
    Pan, Fan
    Zhang, Kun
    Huang, Qian
    Huang, Yuju
    Li, Dongliang
    Lv, Lizhi
    Chen, Man
    Yan, Ruiying
    Lai, Yanhua
    Peng, Yonghai
    Wu, Zhixian
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [40] Sorafenib plus tislelizumab as maintenance therapy for patients with advanced hepatocellular carcinoma treated with transarterial chemoembolization: A phase II study.
    Cai, Mingyue
    Hong, Xiaoyang
    Huang, Wensou
    Guo, Yongjian
    Shi, Wenbo
    Liang, Licong
    Zhou, Jingwen
    Lin, Liteng
    Chen, Ye
    Zhu, Kangshun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 574 - 574
12345